Cargando…

A new method for estimating under-recruitment of a patient registry: a case study with the Ohio Registry of Amyotrophic Lateral Sclerosis

We developed a disease registry to collect all incident amyotrophic lateral sclerosis (ALS) cases diagnosed during 2016–2018 in Ohio. Due to incomplete case ascertainment and limitations of the traditional capture-recapture method, we proposed a new method to estimate the number of cases not recruit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Meifang, Shi, Xun, Gui, Jiang, Song, Chao, Andrew, Angeline S., Pioro, Erik P., Stommel, Elijah W., Tischbein, Maeve, Bradley, Walter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428141/ https://www.ncbi.nlm.nih.gov/pubmed/36042373 http://dx.doi.org/10.1038/s41598-022-18944-9

Ejemplares similares

A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk
por: Re, Diane B., et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis Risk, Family Income, and Fish Consumption Estimates of Mercury and Omega-3 PUFAs in the United States
por: Hoffman, Hannah I., et al.
Publicado: (2021)

Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis
por: Torbick, Nathan, et al.
Publicado: (2017)

Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study
por: Andrew, Angeline S., et al.
Publicado: (2020)

Impact of the National Amyotrophic Lateral Sclerosis Registry: Analysis of Registry‐funded Research
por: Rechtman, Lindsay, et al.
Publicado: (2022)

National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases
por: Barbalho, Ingridy, et al.
Publicado: (2021)

Mapping amyotrophic lateral sclerosis lake risk factors across northern New England
por: Torbick, Nathan, et al.
Publicado: (2014)

Cyanotoxins and the Nervous System
por: Metcalf, James S., et al.
Publicado: (2021)

The Cyanobacteria Derived Toxin Beta-N-Methylamino-L-Alanine and Amyotrophic Lateral Sclerosis
por: Banack, Sandra Anne, et al.
Publicado: (2010)

The Heritability of Amyotrophic Lateral Sclerosis in a Clinically Ascertained United States Research Registry
por: Wingo, Thomas S., et al.
Publicado: (2011)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
por: Nagel, Gabriele, et al.
Publicado: (2013)

Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism
por: Mehta, Paul, et al.
Publicado: (2021)

ResearchMatch on FHIR: Development and evaluation of a recruitment registry and electronic health record system interface for volunteer profile completion
por: Cheng, Alex C., et al.
Publicado: (2023)

Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data
por: Bryan, Leah, et al.
Publicado: (2016)

Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol
por: He, Ji, et al.
Publicado: (2020)

Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
por: Uenal, Hatice, et al.
Publicado: (2014)

CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions
por: Mehta, Paul, et al.
Publicado: (2017)

Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
por: Michels, Sebastian, et al.
Publicado: (2023)

Factors predicting one-year mortality in amyotrophic lateral sclerosis patients – data from a population-based registry
por: Wolf, Joachim, et al.
Publicado: (2014)

Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
por: Nagel, Gabriele, et al.
Publicado: (2017)

Detection of Cyanotoxins, β-N-methylamino-l-alanine and Microcystins, from a Lake Surrounded by Cases of Amyotrophic Lateral Sclerosis
por: Banack, Sandra Anne, et al.
Publicado: (2015)

Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015
por: RAYMOND, JAIME, et al.
Publicado: (2019)

Increasing Patient Self-Enrollment in the National Amyotrophic Lateral Sclerosis Registry: Lessons Learned From a Direct to Provider Campaign
por: Rechtman, Lindsay, et al.
Publicado: (2018)

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation
por: Panchabhai, Tanmay S., et al.
Publicado: (2019)

Brain White Matter Shape Changes in Amyotrophic Lateral Sclerosis (ALS): A Fractal Dimension Study
por: Rajagopalan, Venkateswaran, et al.
Publicado: (2013)

Lung volume recruitment improves volitional airway clearance in amyotrophic lateral sclerosis
por: Cleary, Stuart, et al.
Publicado: (2021)

Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis – Results from the ALS Registry Swabia
por: Nagel, Gabriele, et al.
Publicado: (2020)

Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value
por: Nagel, Gabriele, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis as a synaptopathy
por: Fogarty, Matthew J.
Publicado: (2019)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020)

Long-term survival analysis of masitinib in amyotrophic lateral sclerosis
por: Mora, Jesus S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0bmong4vnfkeqoioo75kg1q7eu